Sign up for our eNewsletter
[f] [t] [in] [blog]

Portfolio Companies

Bioscience
Clean Technology
Information Technology
Medical Device

New Haven Pharmaceuticals

CEO: Patrick Fourteau

Year Established: 2008

Description: New Haven Pharmaceuticals is a specialty pharmaceuticals company developing proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe active pharmaceutical ingredients for use in therapeutic applications that represent significant market opportunities.

Web: http://www.newhavenpharma.com/

CI Representative:
Daniel Wagner
Managing Director, Investments

[photo]